Biomarin Pharmaceutical
Price & Volume
Stats
See more52W Range | $60.63-$94.85 |
Market Cap | $13.5B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $2.8B |
Revenue Growth (YoY) | 15.6% |
Gross Profit (12 Mos) | $2.2B |
Diluted EPS | $2.21 |
News
See moreYahoo Finance • 11 days ago
BioMarin Pharmaceutical Full Year 2024 Earnings: Beats Expectations
Yahoo Finance • last month
Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now?
Yahoo Finance • 7 months ago
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease
Yahoo Finance • 10 months ago
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
About
CEO | Mr. Alexander Hardy |
Address | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,040 |
